These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 31513287)

  • 1. Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: a network meta-analysis.
    Best LM; Freeman SC; Sutton AJ; Cooper NJ; Tng EL; Csenar M; Hawkins N; Pavlov CS; Davidson BR; Thorburn D; Cowlin M; Milne EJ; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD013103. PubMed ID: 31513287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic prophylaxis to prevent spontaneous bacterial peritonitis in people with liver cirrhosis: a network meta-analysis.
    Komolafe O; Roberts D; Freeman SC; Wilson P; Sutton AJ; Cooper NJ; Pavlov CS; Milne EJ; Hawkins N; Cowlin M; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD013125. PubMed ID: 31978256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis.
    Plaz Torres MC; Best LM; Freeman SC; Roberts D; Cooper NJ; Sutton AJ; Roccarina D; Benmassaoud A; Iogna Prat L; Williams NR; Csenar M; Fritche D; Begum T; Arunan S; Tapp M; Milne EJ; Pavlov CS; Davidson BR; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013122. PubMed ID: 33784794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment for bleeding oesophageal varices in people with decompensated liver cirrhosis: a network meta-analysis.
    Roberts D; Best LM; Freeman SC; Sutton AJ; Cooper NJ; Arunan S; Begum T; Williams NR; Walshaw D; Milne EJ; Tapp M; Csenar M; Pavlov CS; Davidson BR; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013155. PubMed ID: 33837526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment for ascites in adults with decompensated liver cirrhosis: a network meta-analysis.
    Benmassaoud A; Freeman SC; Roccarina D; Plaz Torres MC; Sutton AJ; Cooper NJ; Iogna Prat L; Cowlin M; Milne EJ; Hawkins N; Davidson BR; Pavlov CS; Thorburn D; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD013123. PubMed ID: 31978257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic treatment for spontaneous bacterial peritonitis in people with decompensated liver cirrhosis: a network meta-analysis.
    Iogna Prat L; Wilson P; Freeman SC; Sutton AJ; Cooper NJ; Roccarina D; Benmassaoud A; Plaz Torres MC; Hawkins N; Cowlin M; Milne EJ; Thorburn D; Pavlov CS; Davidson BR; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD013120. PubMed ID: 31524949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance immunosuppression for adults undergoing liver transplantation: a network meta-analysis.
    Rodríguez-Perálvarez M; Guerrero-Misas M; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011639. PubMed ID: 28362060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis.
    Roccarina D; Best LM; Freeman SC; Roberts D; Cooper NJ; Sutton AJ; Benmassaoud A; Plaz Torres MC; Iogna Prat L; Csenar M; Arunan S; Begum T; Milne EJ; Tapp M; Pavlov CS; Davidson BR; Tsochatzis E; Williams NR; Gurusamy KS
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013121. PubMed ID: 33822357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction immunosuppression in adults undergoing liver transplantation: a network meta-analysis.
    Best LM; Leung J; Freeman SC; Sutton AJ; Cooper NJ; Milne EJ; Cowlin M; Payne A; Walshaw D; Thorburn D; Pavlov CS; Davidson BR; Tsochatzis E; Williams NR; Gurusamy KS
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD013203. PubMed ID: 31978255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nutritional supplementation for nonalcohol-related fatty liver disease: a network meta-analysis.
    Komolafe O; Buzzetti E; Linden A; Best LM; Madden AM; Roberts D; Chase TJ; Fritche D; Freeman SC; Cooper NJ; Sutton AJ; Milne EJ; Wright K; Pavlov CS; Davidson BR; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013157. PubMed ID: 34280304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological interventions for primary biliary cholangitis: an attempted network meta-analysis.
    Saffioti F; Gurusamy KS; Eusebi LH; Tsochatzis E; Davidson BR; Thorburn D
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011648. PubMed ID: 28350426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Terlipressin versus other vasoactive drugs for hepatorenal syndrome.
    Israelsen M; Krag A; Allegretti AS; Jovani M; Goldin AH; Winter RW; Gluud LL
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD011532. PubMed ID: 28953318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transjugular intrahepatic portosystemic shunts for adults with hepatorenal syndrome.
    Gonzalez-Garay AG; Serralde-Zúñiga AE; Velasco Hidalgo L; Flores García NC; Aguirre-Salgado MI
    Cochrane Database Syst Rev; 2024 Jan; 1(1):CD011039. PubMed ID: 38235907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy for people with hepatocellular carcinoma.
    Naing C; Ni H; Aung HH; Htet NH; Nikolova D
    Cochrane Database Syst Rev; 2024 Jun; 6(6):CD013731. PubMed ID: 38837373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy of pharmacological strategies for management of type 1 hepatorenal syndrome: a systematic review and network meta-analysis.
    Facciorusso A; Chandar AK; Murad MH; Prokop LJ; Muscatiello N; Kamath PS; Singh S
    Lancet Gastroenterol Hepatol; 2017 Feb; 2(2):94-102. PubMed ID: 28403995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological interventions for alcoholic liver disease (alcohol-related liver disease): an attempted network meta-analysis.
    Buzzetti E; Kalafateli M; Thorburn D; Davidson BR; Thiele M; Gluud LL; Del Giovane C; Askgaard G; Krag A; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011646. PubMed ID: 28368093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD): an attempted network meta-analysis.
    Lombardi R; Onali S; Thorburn D; Davidson BR; Gurusamy KS; Tsochatzis E
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011640. PubMed ID: 28358980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Terlipressin versus placebo or no intervention for people with cirrhosis and hepatorenal syndrome.
    Allegretti AS; Israelsen M; Krag A; Jovani M; Goldin AH; Schulman AR; Winter RW; Gluud LL
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD005162. PubMed ID: 29943803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lifestyle modifications for nonalcohol-related fatty liver disease: a network meta-analysis.
    Buzzetti E; Linden A; Best LM; Madden AM; Roberts D; Chase TJG; Freeman SC; Cooper NJ; Sutton AJ; Fritche D; Milne EJ; Wright K; Pavlov CS; Davidson BR; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2021 Jun; 6(6):CD013156. PubMed ID: 34114650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventions for hereditary haemochromatosis: an attempted network meta-analysis.
    Buzzetti E; Kalafateli M; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011647. PubMed ID: 28273330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.